沃华医药(002107.SZ)：实际控制人拟由赵丙贤变为无实际控制人

Core Viewpoint - The recent court ruling regarding the divorce property dispute between Zhao Bingxian and Lu Juan has resulted in a significant change in the control structure of Wohuah Pharmaceutical, as the actual controller status will shift from Zhao Bingxian to a situation with no actual controller [1] Group 1: Court Ruling Details - The Beijing Third Intermediate People's Court upheld the first-instance ruling regarding the division of shares in Zhongzheng Wanrong Investment Group, ordering an equal split of shares between Zhao Bingxian and Lu Juan, each holding 50% [1] - Zhongzheng Wanrong Investment Group currently holds 50.27% of Wohuah Pharmaceutical's shares, maintaining its status as the controlling shareholder [1] Group 2: Impact on Company Control - Following the court's decision, neither Zhao Bingxian nor Lu Juan can individually control Zhongzheng Wanrong Investment Group, leading to a change in the actual control of Wohuah Pharmaceutical [1] - Despite the change in control, Zhao Bingxian continues to serve as the chairman, legal representative, and president of Zhongzheng Wanrong Investment Group, as well as the chairman and legal representative of Wohuah Pharmaceutical, ensuring that company operations remain unaffected [1]